Jonathan Durham gains 79,265 GEMI shares; 7,142 RSUs vest in one year
Rhea-AI Filing Summary
Gemini Space Station director Jonathan B. Durham reported acquisitions on 09/11/2025 that increased his direct holdings to 79,265 shares of Class A common stock. The filing shows a grant of 7,142 restricted stock units (RSUs) that vest in full on the first anniversary of the grant date, subject to continued service; each RSU converts to one share upon vesting. It also discloses receipt of 72,123 Class A shares issued in connection with the issuer's initial public offering in exchange for Durham's incentive profits interest units in Gemini Astronaut Corps, LLC. The Form 4 was signed by an attorney-in-fact on 09/15/2025.
Positive
- Director increased direct ownership to 79,265 Class A shares following the transactions
- 72,123 shares received in connection with the issuer's initial public offering converting incentive profits interest units to Class A stock
- 7,142 RSUs granted that vest in full after one year, aligning executive interest with shareholder outcomes
Negative
- None.
Insights
TL;DR: Insider acquisitions increased the director's direct stake to 79,265 Class A shares, combining an IPO exchange and time‑vested RSUs.
The reported transactions show a meaningful shift from incentive units to public Class A shares: 72,123 shares were issued in the IPO conversion and 7,142 RSUs were granted that vest after one year. For analysts, the conversion of incentive units into publicly traded shares clarifies outstanding ownership and aligns compensation with equity performance. The RSU vesting schedule ties future share delivery to continued service, which is a common retention mechanism.
TL;DR: Director received shares via IPO reorganization and a one‑year RSU grant; governance impact is routine but increases disclosed insider ownership.
The Form 4 discloses direct beneficial ownership after the transactions and confirms the RSUs are service‑based with a one‑year cliff. This is a standard retention and alignment practice and the filing was executed by an attorney‑in‑fact. No departures, option repricings, or other unusual governance actions are disclosed.